ArticleTargeted oncology2021

Real-World Healthcare Resource Utilization in Patients with Classical Hodgkin Lymphoma Treated with Pembrolizumab and Nivolumab in the USA.

François Laliberté et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.